Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels

Clinical trial NCT05458102 · TERMINATED

Trial details

NCT number: NCT05458102
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Start date: 2022-08-19
Primary completion: 2023-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.